3 Must-Buy Stocks Right Now: Top Analysts’ Picks for August 20, 2025

Market momentum shifts as institutional money floods into equities—analysts pinpoint three standout performers poised for explosive growth.

Tech Sector Leads Charge

AI infrastructure plays dominate recommendations as compute demand skyrockets 300% year-over-year. Semiconductor manufacturers crushing earnings expectations while traditional value stocks languish.

Energy Transition Gold Rush

Clean tech companies leveraging new DOE grants outperforming benchmarks by 47%—solar and battery storage plays becoming institutional darlings despite retail investor skepticism.

Financial Services Disruption

Neobanks and payment processors eating traditional banking lunch with 22% lower customer acquisition costs. Regulatory tailwinds creating perfect storm for fintech expansion.

Wall Street's usual circus of downgrades-upgrades-downgrades continues—because nothing says 'conviction' like changing your price target every time the wind shifts direction.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

(OPRA) – Opera is a web browser and digital services company known for its mobile apps, fintech products, and AI-driven features. Today, TD Cowen analyst Lance Vitanza maintained a Buy rating on the stock with a price target of $33 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 66.23%.

(HIVE) – This is a cryptocurrency mining and blockchain infrastructure company focused on sustainable digital asset operations. Yesterday, H.C. Wainwright analyst Mike Colonnese maintained a Buy rating on the stock with a price target of $6 per share. Interestingly, five out of the six Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 169.87%. 

(SLNO) – This is a biopharmaceutical company developing therapies for rare endocrine and metabolic disorders. Yesterday, Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on the stock with a price target of $123 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 81.11%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page.